Non-specific Response to H1N1 Vaccine
|ClinicalTrials.gov Identifier: NCT01178918|
Recruitment Status : Unknown
Verified August 2010 by The University Clinic of Pulmonary and Allergic Diseases Golnik.
Recruitment status was: Active, not recruiting
First Posted : August 10, 2010
Last Update Posted : August 10, 2010
This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||15 participants|
|Official Title:||Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine|
|Study Start Date :||November 2009|
|Healthy volunteers from recipients of H1N1 vaccine|
- T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination [ Time Frame: At 3 weeks after vaccination ]
- T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination [ Time Frame: At 11 weeks after vaccination. ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01178918
|University Clinic of Respiratory and Allergic Diseases|
|Golnik, Slovenia, 4204|